Trial intelligence / Profile preview

VRVg-2 rabies vaccine in healthy adults

NCT04594551Phase 3Completed

Sponsor
Sanofi
Start
Oct 2020
Primary completion
Jun 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of rabies vaccine serum-free vero cell in rabies, sponsored by Sanofi. Started Oct 2020; status: completed.

02

Drugs

rabies vaccine serum-free vero cell
03

Conditions

rabies

Beyond the preview

Go deeper on NCT04594551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04594551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call